Format

Send to

Choose Destination
Presse Med. 2015 Jul-Aug;44(7-8):752-60. doi: 10.1016/j.lpm.2015.05.004. Epub 2015 Jul 22.

[From FRANCE 2 to FRANCE TAVI: are indications, technique and results of transcatheter aortic valve replacement the same?].

[Article in French]

Author information

1
CHU de Rennes, service de cardiologie et des maladies vasculaires, 35000 Rennes, France; Université Rennes 1, LTSI, 35000 Rennes, France; Inserm U1099, 35000 Rennes, France. Electronic address: vincent.auffret@chu-rennes.fr.
2
CHU de Rennes, service de cardiologie et des maladies vasculaires, 35000 Rennes, France; Université Rennes 1, LTSI, 35000 Rennes, France; Inserm U1099, 35000 Rennes, France.
3
Université Rennes 1, LTSI, 35000 Rennes, France; Inserm U1099, 35000 Rennes, France; CHU de Rennes, service de chirurgie thoracique et cardiovasculaire, 35000 Rennes, France.
4
Clinique Saint-Hilaire, service de cardiologie, 76000 Rouen, France.
5
CHU de Limoges, département de chirurgie cardiovasculaire, 87000 Limoges, France.
6
Université Lille 2, CHRU de Lille, département de cardiologie, Inserm U1011, FHU Integra, 59000 Lille, France.
7
Université Sorbonne - Pierre-et-Marie-Curie, AP-HP, GHPS, chirurgie cardiaque, 75005 Paris, France.
8
AP-HP, CHU La Pitié-Salpêtrière, service de cardiologie, 75013 Paris, France.
9
DHU Fire et université Paris-Diderot, AP-HP, hôpital Bichat, département de cardiologie, 75018 Paris, France.
10
Institut cardiovasculaire Paris-Sud, hôpital privé Jacques-Cartier, 91300 Massy, France.
11
CHU Rouen - Charles-Nicolle, Inserm U644, 76031 Rouen, France.
12
CHU de Brest, La Cavale-Blanche, 29200 Brest France.

Abstract

Transcatheter aortic valve implantation (TAVI) is indicated in patients with severe symptomatic aortic stenosis who are not suitable for surgery or should be considered when there is a high surgical risk as assessed by a heart team. There is a decrease in mean logistic EuroSCORE since January 2010, which translates a gradual evolution in patients' selection. Expertise of geriatricians to further assess frailty is a key step in the risk stratification process of this elderly population (mean age: 83.4±7.3 years). Femoral access is used in 80% of cases with a procedural success rate higher than 95%. In-hospital mortality rate is 5.9%. The main complications of the procedure are aortic annulus rupture (0.9% in FRANCE TAVI), tamponade (2.3%), stroke (2.2%), severe paravalvular leak (1.3%) and permanent pacemaker implantation (15%). The awaited results of PARTNER II and SURTAVI may lead to expand the indications to lower-risk patients if it is shown that TAVI is non-inferior to surgery in this population which has been suggested by the recent randomized NOTION Trial while the CoreValve Pivotal Trial even points in the direction of a possible superiority of the percutaneous technique over surgery.

PMID:
26208911
DOI:
10.1016/j.lpm.2015.05.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center